These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 7572071)
21. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy. Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882 [TBL] [Abstract][Full Text] [Related]
22. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations. Cupler EJ; Danon MJ; Jay C; Hench K; Ropka M; Dalakas MC Acta Neuropathol; 1995; 90(1):1-6. PubMed ID: 7572071 [TBL] [Abstract][Full Text] [Related]
23. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine. Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554 [TBL] [Abstract][Full Text] [Related]
24. Prognosis in AZT myopathy. Chalmers AC; Greco CM; Miller RG Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057 [TBL] [Abstract][Full Text] [Related]
25. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Pezeshkpour G; Illa I; Dalakas MC Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434 [TBL] [Abstract][Full Text] [Related]
27. Zidovudine-induced myopathy: A study in Indian patients. Sagar A; Mohanty AP; Bahal A J Neurosci Rural Pract; 2010 Jul; 1(2):63-6. PubMed ID: 21808505 [TBL] [Abstract][Full Text] [Related]
28. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955 [TBL] [Abstract][Full Text] [Related]
30. Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine. Chariot P; Benbrik E; Schaeffer A; Gherardi R Acta Neuropathol; 1993; 85(4):431-6. PubMed ID: 8386898 [TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy. Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345 [TBL] [Abstract][Full Text] [Related]
32. HIV or zidovudine myopathy? Dalakas M Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594 [No Abstract] [Full Text] [Related]
33. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Chariot P; Monnet I; Gherardi R Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243 [TBL] [Abstract][Full Text] [Related]
34. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Dalakas MC; Leon-Monzon ME; Bernardini I; Gahl WA; Jay CA Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877 [TBL] [Abstract][Full Text] [Related]
35. AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Modica-Napolitano JS Biochem Biophys Res Commun; 1993 Jul; 194(1):170-7. PubMed ID: 8101441 [TBL] [Abstract][Full Text] [Related]
37. Studies on the inhibition of mitochondrial DNA replication by 3'-azido-3'-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication. Simpson MV; Chin CD; Keilbaugh SA; Lin TS; Prusoff WH Biochem Pharmacol; 1989 Apr; 38(7):1033-6. PubMed ID: 2706007 [No Abstract] [Full Text] [Related]
38. Biogenesis of mitochondria. Attardi G; Schatz G Annu Rev Cell Biol; 1988; 4():289-333. PubMed ID: 2461720 [No Abstract] [Full Text] [Related]